Research workbench
Crystal structure of human NDRG3 C30S mutant
Analyse Crystal structure of human NDRG3 C30S mutant in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 6L4H
- Type
- protein
- Length
- 1,117 residues
- Chains
- 4
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Protein NDRG3
- UniProt
- Q9UGV2
- Pockets
- 16 · best druggability 0.81
Structure
x-ray diffraction · 2 distinct chains · 39% helix, 18% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Protein NDRG3 | protein | 289 | 38% helix, 17% strand | Q9UGV2 |
| B, C, D | Protein NDRG3 | protein | 276 | 41% helix, 20% strand | Q9UGV2 |
Pockets
16 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 225 | 0.81 | 0.94 | 33 | empty |
| 2 | 228 | 0.80 | 0.94 | 33 | empty |
| 3 | 795 | 0.77 | 0.81 | 77 | empty |
| 4 | 463 | 0.70 | 0.81 | 58 | empty |
| 5 | 416 | 0.62 | 0.77 | 54 | empty |
Interfaces
5 interfaces between chains.
- A–B · 852 Ų buried · 5 hydrogen bonds · protein-protein
- C–D · 744 Ų buried · 6 hydrogen bonds · protein-protein
- A–C · 527 Ų buried · 3 hydrogen bonds · protein-protein
- B–C · 379 Ų buried · 3 hydrogen bonds · protein-protein
- B–D · 27 Ų buried · 0 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9UGV2
- Elsewhere: RCSB PDB 6L4H · PDBe 6L4H · UniProt Q9UGV2
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.